📊 AXPH: Strong Fundamentals, Stretched Technical ⚠️

🏛️ Fundamental Review:
📊 Business Quality.
AXPH is a highly profitable pharmaceutical manufacturer with exceptional profitability and a defensive business model. 🏥
✅ Strengths & Catalysts.
A 49.3% ROE, almost debt free balance sheet, and an attractive 5.7% dividend yield make it a premium defensive stock. 🚀
⚠️ Risks.
Very limited share float and slowing quarterly momentum increase volatility and liquidity risk. ⚠️
💰 Valuation.
AXPH is an elite long term value stock, but current prices trade well above my calculated fair value. 💎

🔍 The Pulse:
AXPH confirmed a momentum breakout from a flag pattern. 📈
The rally has pushed the stock into an overbought and stretched technical position. ⚠️
My calculated fair value stands near 980 EGP, well below the current price. 💎
For aggressive investors, I prefer accumulating on a pullback around 1,187 EGP. 🎯
If price fails to break 1,378 EGP next week, a deeper pullback toward 1,156 EGP becomes increasingly likely. 🔄

🧱 The Key Structural Boundaries

🛡️ First Support, 1,156 EGP.
The previous major resistance that should act as support on any correction.

🛡️ Recommended Entry, 1,187 EGP.
My preferred accumulation level for investors willing to accept the risk.

🚀 Breakout Trigger, 1,378 EGP.
A close above this level confirms the next bullish expansion.

💎 Fair Value, 980 EGP.
My calculated fair value for the stock.

🎯 The Verdict:
AXPH remains one of the strongest defensive businesses on the EGX.
The technical picture is bullish, but the stock is significantly stretched.
Avoid chasing the current rally and wait for a healthier entry.
A failure to break 1,378 EGP could trigger a pullback toward 1,156 EGP.

---

If you like my insights, follow and boost! 🙌💙🚀

🎁 $15 TradingView Discount:
🔗 https://www.tradingview.com/pricing/?share_your_love=mnmabroukw36ix ✨💸🤑